Featured 13F manager
Patient Capital Management, LLC Samantha McLemore
Baltimore, MD 19 processed 13Fs on this site · 2021 Q4–2026 Q2
- $3.1B
- 39 Positions
- 2026 Q2
- +11.5% QoQ
- Top 5 30.5%
Portfolio
top 5 30.5% · top 10 51.3%
- RPRX - Royalty Pharma · CLASS A 6.6%
- C - Citigroup 6.4%
- GOOGL - Alphabet · CL A 6.2%
- UNH - Unitedhealth Group 6.0%
- AMZN - Amazon 5.3%
- NVDA - Nvidia 4.6%
- CVS - Cvs Health 4.2%
- NCLH - Norwegian Cruise Line 4.2%
- QXO - QXO Inc 4.0%
- ET - Energy Transfer L P 3.8%
- IAC - People 3.7%
- PGEN - Precigen 3.6%
- Other 41.4%
AUM over time
Book
| OVV - Ovintiv | 5.92% | Reduce −1.6% | 257,900 | $46.00 | $12M | −4,100 | +$285K |
| EXPE - Expedia Group | 5.90% | Add +37.1% | 126,200 | $93.69 | $12M | +34,125 | +$3M |
| TEVA - Teva Pharmaceutical Inds | 4.73% | Reduce −1.5% | 1,175,000 | $8.07 | $9M | −17,950 | +$511K |
| AMZN - Amazon | 4.49% | Add +9.3% | 79,700 | $113.00 | $9M | +6,800 | +$1M |
| ET - Energy Transfer L P | 4.19% | Hold | 761,400 | $11.03 | $8M | — | — |
| OMF - Onemain | 4.11% | Add +24.3% | 278,900 | $29.52 | $8M | +54,525 | −$154K |
| MAT - Mattel | 4.10% | Reduce −7.2% | 433,300 | $18.94 | $8M | −33,700 | −$2M |
| BABA - Alibaba Group | 3.67% | Reduce −25.9% | 92,050 | $79.99 | $7M | −32,150 | −$7M |
| FISV - Fiserv | 3.49% | Reduce −2.0% | 74,700 | $93.57 | $7M | −1,500 | +$210K |
| GOOGL - Alphabet · CL A | 3.40% | Add +1900.0% | 71,200 | $95.65 | $7M | +67,640 | −$948K |
| UBER - UBER Technologies | 3.04% | Add +1.7% | 229,900 | $26.50 | $6M | +3,750 | +$1M |
| GM - General Mtrs | 3.01% | Reduce −2.0% | 187,700 | $32.09 | $6M | −3,800 | −$59K |
| DAL - Delta Air Lines Del | 2.94% | Add +2.4% | 210,300 | $28.06 | $6M | +5,000 | −$47K |
| Farfetch · CL A | 2.84% | Add +25.1% | 763,000 | $7.45 | $6M | +153,000 | +$1M |
| C - Citigroup | 2.82% | Hold | 135,800 | $41.67 | $6M | — | — |
| NCLH - Norwegian Cruise | 2.64% | Add +2.2% | 465,250 | $11.36 | $5M | +10,000 | +$223K |
| META - Meta Platforms · CL A | 2.61% | Reduce −21.1% | 38,530 | $135.69 | $5M | −10,320 | −$3M |
| CLF - Cleveland-Cliffs | 2.47% | Hold | 367,200 | $13.47 | $5M | — | — |
| DXC - Dxc Technology | 2.32% | Reduce −30.0% | 190,000 | $24.48 | $5M | −81,600 | −$4M |
| JPM - Jpmorgan Chase & | 2.32% | Add +10.8% | 44,450 | $104.50 | $5M | +4,350 | +$129K |
| UAL - United Airls | 2.27% | Add +0.9% | 139,800 | $32.53 | $5M | +1,300 | −$358K |
| COIN - Coinbase Global · CL A | 2.24% | Add +198.3% | 69,500 | $64.49 | $4M | +46,200 | +$3M |
| TMHC - Taylor Morrison Home | 2.19% | Reduce −2.4% | 188,600 | $23.32 | $4M | −4,700 | −$117K |
| TNL - Travel Plus Leisure | 2.00% | Add +24.2% | 117,200 | $34.12 | $4M | +22,850 | +$336K |
| Karuna Therapeutics | 1.99% | Reduce −8.3% | 17,700 | $224.92 | $4M | −1,600 | +$2M |
| ADT - ADT Del | 1.82% | Reduce −25.3% | 485,700 | $7.49 | $4M | −164,350 | −$360K |
| Splunk | 1.79% | Reduce −3.7% | 47,575 | $75.21 | $4M | −1,825 | −$792K |
| FANG - Diamondback Energy | 1.73% | Reduce −12.5% | 28,800 | $120.45 | $3M | −4,100 | −$517K |
| RKT - Rocket Cos · CL A | 1.70% | Reduce −15.0% | 537,700 | $6.32 | $3M | −95,100 | −$1M |
| GOOS - Canada Goose | 1.32% | New | 173,900 | $15.24 | $3M | +173,900 | +$3M |
| COF - Capital One Finl | 1.32% | Reduce −7.6% | 28,700 | $92.16 | $3M | −2,350 | −$590K |
| SFIX - Stitch Fix · CL A | 1.31% | New | 662,350 | $3.95 | $3M | +662,350 | +$3M |
| SOFI - SOFI Technologies | 1.14% | Add +102.8% | 469,700 | $4.88 | $2M | +238,100 | +$1M |
| Quotient Technology | 1.04% | Hold | 906,000 | $2.31 | $2M | — | — |
| EXE - Chesapeake Energy | 1.03% | New | 22,000 | $94.23 | $2M | +22,000 | +$2M |
| BHC - Bausch Health Cos | 0.65% | Reduce −53.7% | 187,600 | $6.89 | $1M | −217,900 | −$2M |
| VNT - Vontier | 0.54% | Reduce −67.0% | 65,000 | $16.71 | $1M | −131,800 | −$3M |
| BAC - Bank of America | 0.38% | Hold | 25,000 | $30.20 | $755K | — | — |
| LEN.B — · CL B | 0.37% | Hold | 12,500 | $59.52 | $744K | — | — |
| PGEN - Precigen | 0.32% | Hold | 298,200 | $2.12 | $632K | — | — |
| BRLT - Brilliant Earth Group · CL A | 0.21% | New | 75,000 | $5.73 | $430K | +75,000 | +$430K |
Exits / last held
not current holdings · last reported size, unchanged · gone vs 2022 Q2
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| Avid Technology | 1.00% | Exit | 0 | $25.95 | $2M | −86,700 | −$2M |
| Proshares Tr Ii | 0.19% | Exit | 0 | $41.90 | $419K | −10,000 | −$419K |
Filings history
19 periods · normalized AUM · open a period for holdings
| Period | Holdings | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 40 | $3.1B | +11.5% | 13F-HR | 8/13/2026 | 000185479426000005 |
| 2026 Q1 | 40 | $2.7B | +5.6% | 13F-HR | 5/14/2026 | 000185479426000004 |
| 2025 Q4 | 40 | $2.6B | +3.7% | 13F-HR | 2/13/2026 | 000185479426000003 |
| 2025 Q3 | 41 | $2.5B | +12.7% | 13F-HR | 10/30/2025 | 000185479425000004 |
| 2025 Q2 | 40 | $2.2B | +13.9% | 13F-HR | 8/13/2025 | 000108514625004963 |
| 2025 Q1 | 39 | $1.9B | −10.2% | 13F-HR | 5/14/2025 | 000108514625003124 |
| 2024 Q4 | 43 | $2.2B | +6.4% | 13F-HR | 2/14/2025 | 000108514625001553 |
| 2024 Q3 | 41 | $2B | +8.2% | 13F-HR | 11/14/2024 | 000108514624005800 |
| 2024 Q2 | 40 | $1.9B | −8.3% | 13F-HR | 8/14/2024 | 000108514624003874 |
| 2024 Q1 | 42 | $2.1B | +8.8% | 13F-HR | 5/15/2024 | 000108514624002548 |
| 2023 Q4 | 43 | $1.9B | +10.8% | 13F-HR | 2/14/2024 | 000108514624001375 |
| 2023 Q3 | 42 | $1.7B | −5.2% | 13F-HR | 11/14/2023 | 000108514623004442 |
| 2023 Q2 | 44 | $1.8B | +702.2% | 13F-HR | 8/14/2023 | 000108514623003400 |
| 2023 Q1 | 42 | $224M | +8.7% | 13F-HR | 5/15/2023 | 000108514623002385 |
| 2022 Q4 | 43 | $206M | +3.0% | 13F-HR | 2/14/2023 | 000108514623001252 |
| 2022 Q3 | 42 | $200M | −11.5% | 13F-HR | 11/14/2022 | 000108514622004043 |
| 2022 Q2 | 42 | $226M | −23.4% | 13F-HR | 8/15/2022 | 000108514622003092 |
| 2022 Q1 | 45 | $295M | −15.0% | 13F-HR | 5/16/2022 | 000108514622002149 |
| 2021 Q4 | 43 | $347M | — | 13F-HR | 2/14/2022 | 000108514622001017 |
About
Patient Capital Management, LLC
19 processed 13Fs on this site · 2021 Q4–2026 Q2